India: Anti-Cancer Drug 137-da Trade Margin Limit Thambiba Government-gi Decision

New Delhi, October 18, 2026

India-gi government-na anti-cancer drug 137-gi trade margin asi 30 percent-da limit touba decision ama loure. Decision asi cancer treatment-gi cost adu control touba amasung patient-singna medicine phangba khudongchaba hen-gatnaba hotnaba oina loukhiba policy ama ni.

Cancer treatment-gi maramda patient-singna medicine, hospital charge amasung atoppa medical expense-singda achouba kharcha louba yai. Trade margin limit touba asi medicine-gi price adu control tounaba mateng pangba yai, adubu patient-sing-gi actual treatment cost adu medicine-gi price khaktana depend toude.

Government-gi regulation asi drug manufacturer, wholesaler amasung retailer-sing-gi marakta trade margin-gi limit thambiba matungda implement toujagani. Policy asi patient-singna cancer medicine phangba matamda cost-gi maramda phangba pressure adu kanglaba hotnaba pandam oiri.

Source: The Indian Express — India news archive, October 18⁠

Leave a Comment